Literature DB >> 28209989

Regulatory watch: The target product profile as a tool for regulatory communication: advantageous but underused.

Adria Tyndall1,2, Wenny Du3,2, Christopher D Breder4.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28209989      PMCID: PMC5478920          DOI: 10.1038/nrd.2016.264

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.

Authors:  Jeffrey Cummings; Aaron Ritter; Kate Zhong
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Rapid point-of-care testing for COVID-19: quality of supportive information for lateral flow serology assays.

Authors:  Patrick Kierkegaard; Anna McLister; Peter Buckle
Journal:  BMJ Open       Date:  2021-03-19       Impact factor: 2.692

3.  Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.

Authors:  Ting Wang; Neil McAuslane; Wim G Goettsch; Hubert G M Leufkens; Marie L De Bruin
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

4.  Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile.

Authors:  Christoph Gerlinger; Thomas Evers; Jeremy Rassen; Richard Wyss
Journal:  Drugs Real World Outcomes       Date:  2020-09

5.  Analysis of the Health Product Profile Directory - a new tool to inform priority-setting in global public health.

Authors:  R F Terry; A Plasència; J C Reeder
Journal:  Health Res Policy Syst       Date:  2019-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.